Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy
接受利妥昔单抗治疗失败后,EBV阳性PTLD患者在异基因造血干细胞移植后的预后
期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-023-02127-9
Socié, Gérard; Barba, Pere; Barlev, Arie; Sanz, Jaime; García-Cadenas, Irene; Chevallier, Patrice; Fagioli, Franca; Guzman-Becerra, Norma; Kumar, Deepali; Ljungman, Per; Pigneux, Arnaud; Sadetsky, Natalia; Yáñez San Segundo, Lucrecia; Shadman, Mazyar; Storek, Jan; Thirumalai, Dhanalakshmi; Xing, Baodong; Mohty, Mohamad